Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-22-000029 General Corporate
Debt relative to revenue 40th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.debt_to_revenue
511.82% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.31% · OPTIONAL · VALID
Operating cash generation 43th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
45.24% · OPTIONAL · VALID
Revenue growth 91th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.revenue
15.79% · CORE · VALID
Inventory pressure 80th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
19.72% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.gross_margin
65.52% · CORE · VALID
Operating margin 100th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.operating_margin
40.33% · CORE · VALID
R&D intensity 0th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.65% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
5.02% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Feb 3, 2019 0/8 normalized Level 3 May 5, 2019 0/9 normalized Level 3 Aug 4, 2019 0/9 normalized Level 3 Nov 3, 2019 0/9 normalized Level 3 Feb 2, 2020 0/9 normalized Level 3 May 3, 2020 6/9 normalized Level 3 Aug 2, 2020 8/9 normalized Level 3 Nov 1, 2020 8/9 normalized Level 3 Jan 31, 2021 8/9 normalized Level 3 May 2, 2021 9/9 normalized Level 3 Aug 1, 2021 9/9 normalized Level 3 Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 8/8 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 144.50%
Current 511.82%
Delta 367.32% Capex Intensity Decreased
Previous 1.61%
Current 1.31%
Delta -0.30% Cash Generation Decreased
Previous 50.14%
Current 45.24%
Delta -4.90% Growth Increased
Previous 14.91%
Current 15.79%
Delta 0.88% Inventory Pressure Increased
Previous 4.72%
Current 19.72%
Delta 15.00% Margin Increased
Previous 61.36%
Current 65.52%
Delta 4.16% Profitability Increased
Previous 31.03%
Current 40.33%
Delta 9.30% R And D Intensity Decreased
Previous 17.68%
Current 15.65%
Delta -2.03% Sbc Intensity Decreased
Previous 6.21%
Current 5.02%
Delta -1.19% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.